A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities. | Medchemcomm;4(5): 847-851, 2013 May 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Yuan, Yunyun; Arnatt, Christopher K; El-Hage, Nazira; Dever, Seth M; Jacob, Joanna C; Selley, Dana E; Hauser, Kurt F; Zhang, Yan.

Affiliation

Yuan Y; Department of Medicinal Chemistry, Virginia Commonwealth University, 800 East Leigh Street, Richmond, VA 23298, USA.

Medchemcomm ; 4(5): 847-851, 2013 May 01.

Article in En | MEDLINE | ID: mdl-23682308

Key words

CCR5; MOR; NeuroAIDS; bivalent ligand; functional selectivity

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Medchemcomm Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Medchemcomm Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom